MA49148A - Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisation - Google Patents

Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisation

Info

Publication number
MA49148A
MA49148A MA049148A MA49148A MA49148A MA 49148 A MA49148 A MA 49148A MA 049148 A MA049148 A MA 049148A MA 49148 A MA49148 A MA 49148A MA 49148 A MA49148 A MA 49148A
Authority
MA
Morocco
Prior art keywords
dgla
acid
pharmaceutical compositions
compositions consisting
pharmaceutical
Prior art date
Application number
MA049148A
Other languages
English (en)
Inventor
John Climax
David Coughlan
Mehar Manku
Original Assignee
Ds Biopharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ds Biopharma Ltd filed Critical Ds Biopharma Ltd
Publication of MA49148A publication Critical patent/MA49148A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MA049148A 2017-05-19 2018-05-17 Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisation MA49148A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762508818P 2017-05-19 2017-05-19

Publications (1)

Publication Number Publication Date
MA49148A true MA49148A (fr) 2020-03-25

Family

ID=62791771

Family Applications (1)

Application Number Title Priority Date Filing Date
MA049148A MA49148A (fr) 2017-05-19 2018-05-17 Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisation

Country Status (6)

Country Link
US (1) US20180333382A1 (fr)
EP (1) EP3624787A1 (fr)
JP (1) JP2020520938A (fr)
CN (1) CN110996937A (fr)
MA (1) MA49148A (fr)
WO (1) WO2018211325A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022114200A1 (fr) * 2020-11-30 2022-06-02 花王株式会社 Procédé de détection de degré d'affection de dermatite atopique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5546087B2 (ja) * 2005-02-14 2014-07-09 サントリーホールディングス株式会社 皮膚疾患経口治療または予防剤
US9006287B2 (en) * 2005-02-14 2015-04-14 Suntory Holdings Limited Composition comprising dihomo-γ-linolenic acid (DGLA) as active ingredient
US7485323B2 (en) 2005-05-31 2009-02-03 Gelita Ag Process for making a low molecular weight gelatine hydrolysate and gelatine hydrolysate compositions
SG10201912145VA (en) * 2014-06-04 2020-02-27 Dignity Sciences Ltd Pharmaceutical compositions comprising dgla and use of same
EP3399971A1 (fr) * 2016-01-07 2018-11-14 DS Biopharma Limited Compositions pharmaceutiques comprenant de dgla et leur utilisation

Also Published As

Publication number Publication date
EP3624787A1 (fr) 2020-03-25
US20180333382A1 (en) 2018-11-22
JP2020520938A (ja) 2020-07-16
CN110996937A (zh) 2020-04-10
WO2018211325A1 (fr) 2018-11-22

Similar Documents

Publication Publication Date Title
MA52257A (fr) Compositions pharmaceutiques comprenant blautia et leur administration orale
MA52644A (fr) Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisation
MA51200A (fr) Nouveaux composés et compositions pharmaceutiques associées pour le traitement de maladies
MA51796A (fr) Procédés et compositions pour l'administration de protéines thérapeutiques
MA41999A (fr) Compositions d'acide obéticholique et procédés d'utilisation
EP4374851A3 (fr) Composition ophtalmique pour le traitement d'une maladie de l' il sec
WO2017087608A8 (fr) Modulateurs de ror-gamma
LU92577B1 (fr) Nouveaux composés et compositions pharmaceutiques de ceux-ci pour le traitement de la mucoviscidose
FR3032353B1 (fr) Composition pharmaceutique et dispositif pour le traitement de la douleur
MA46044A (fr) Compositions de nettoyage comprenant un acide aminé et leurs procédés d'utilisation
MA43361A (fr) Composition pour le soin et la protection de cultures
IL274578A (en) Pharmaceutical compounds and preparations thereof for use in the treatment of leiftic diseases
MA55015A (fr) Formulations pharmaceutiques
MA48461A (fr) Excipients pour réduire la viscosité de formulations d'anticorps et compositions de formulation
MA41326A (fr) Formulations pharmaceutiques comprenant du cangrelor de haute pureté et leurs procédés de préparation et d'utilisation
MA41120A (fr) Compositions comprenant le 15-hepe et méthodes de traitement ou de prévention de la fibrose à l'aide de celles-ci
MA47141A (fr) Compositions comprenant du15-oxo-epa ou du 15-oxo-dgla et leurs procédés de préparation et d'utilisation
MA49524A (fr) Compositions d'antagoniste de nk-1 et méthodes destinées à être utilisées dans le traitement de la dépression
MA49947A (fr) Compositions pharmaceutiques contenant des anticorps anti-bêta-amyloïdes
MA45158A (fr) Composition pharmaceutique comprenant de l'éteplirsen
MA53466A (fr) Formulation stable d'anticorps anti-osmr
MA44286A (fr) Formulation pharmaceutique de cinéol et d'amoxicilline
MA53333A (fr) Formulations pharmaceutiques d'anticorps masqués
MA53099A (fr) Formes d'ivosidénib et compositions pharmaceutiques
MA49148A (fr) Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisation